3,4-dihydroxyphenylacetic acid has been researched along with n-(2-propynyl)-2-(5-benzyloxy-indolyl) methylamine in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ballini, C; Bolea, I; Colivicchi, MA; Della Corte, L; Marco-Contelles, J; Tipton, KF; Unzeta, M | 1 |
1 other study(ies) available for 3,4-dihydroxyphenylacetic acid and n-(2-propynyl)-2-(5-benzyloxy-indolyl) methylamine
Article | Year |
---|---|
Neuroprotective effects of the MAO-B inhibitor, PF9601N, in an in vivo model of excitotoxicity.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Dopamine; Excitatory Amino Acid Agonists; Indoles; Male; Microdialysis; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Neuroprotective Agents; Random Allocation; Rats; Rats, Wistar | 2014 |